
    
      To evaluate the bioequivalence of two formulations of Sarpogrelate HCl 300mg, Anpl-one SR
      Tab. 300mg (Reference) and generic Sarpogrelate HCl 300mg (Test), after a single oral dose
      administration in healthy volunteers under fasting condition: open label, single-dose,
      randomized, two-period, two-treatment, two-sequence, crossover, comparative bioavailability
      study
    
  